© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
November 03, 2014
A light-emitting diode (LED) device that uses 40 high-intensity blue LEDs, which can be configured to an individual patient's needs, and is free of ultraviolet (UV) light, may offer a new treatment option for patients with psoriasis.
October 31, 2014
The compound AIN457 (secukinumab) has been granted a unanimous vote of support for approval from the Dermatologic and Ophthalmic Drugs Advisory Committee to the Food and Drug Administration.
Amgen has released positive top-line results from the first of two Phase III studies of ABP 501, its candidate for the treatment of moderate-to-severe plaque psoriasis that is being developed as a biosimilar to adalimumab.
October 16, 2014
News from the literature on a possible link between atherosclerosis and psoriasis and quality of life for patients with this skin condition.
Aaron Kowalski, PhD: Connecting the Dots with the Type 1 Diabetes Index
Plaque Psoriasis Treated With Tildrakizumab Shown to be Effective in Real-World Settings
Predominantly Persistent IRF in nAMD Eyes Linked to Worse Long-Term Visual Acuity